Navidea Biopharmaceuticals (NAVB) is a biomedical company engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians. This stock is trading up 5.4% to $2.69 in recent trading.
Today's Range: $2.65-$2.76
52-Week Range: $2.14-$4.77Volume: 2.36 million Three-Month Average Volume: 1.46 million Shares of NAVB are trending higher today after the company reported favorable new clinical trial results for its imaging agent Lymphoseek. From a technical perspective, NAVB is spiking higher here and gapping up right above some near-term support at $2.42 with above-average volume. This stock had been downtrending for the last month, with shares moving lower from its high of $3.59 to its recent low of $2.42. During that move, shares of NAVB had been mostly making lower highs and lower lows, which is bearish technical price action. That said, shares of NAVB are now spiking off news and quickly moving within range of triggering a near-term breakout trade. That trade will hit if NAVB manages to take out some near-term overhead resistance at $2.79 and then once it clears both its 50-day at $3 and its 200-day at $3.16 with high volume. Traders should now look for long-biased trades in NAVB as long as it's trending above $2.42, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.46 million shares. If that breakout triggers soon, then NAVB will set up to re-test or possibly take out its next major overhead resistance levels at $3.59 to $4.00. Enphase Energy Enphase Energy (ENPH) has pioneered a new inverter technology for the solar industry that increases energy production, simplifies design and installation, improves system uptime and reliability, and reduces fire safety risk. This stock is trading up 2.8% to $5.84 in recent trading. Today's Range: $5.69-$6.03 52-Week Range: $1.92-$9.57 Volume: 118,000 Three-Month Average Volume: 256,907 From a technical perspective, ENPH is bouncing higher here right off some near-term support at $5.54 with lighter-than-average volume. This stock has been uptrending strong for the last five months, with shares soaring higher from its low of $1.92 to its recent high of $6.70. During that uptrend, shares of ENPH have been consistently making higher lows and higher highs, which is bullish technical price action. That move is now pushing shares of ENPH within range of triggering a breakout trade. That trade will hit if ENPH manages to take out some key overhead resistance levels at 6.70 to $6.89 with high volume.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV